injectable glp 1 agonist GLP-1 Agonists for Weight Loss: Safe or Risky? Glucagon-like peptide-1 (GLP-1) receptor agonists

American Association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity

Nevertheless, future studies should further collect real-world data outcomes or conduct rigorous clinical trials to thoroughly investigate the relationship between GLP-1 RAs and mood disorders

Another treatment combination with synergistic effects on homeostatic parameters involves GLP-1R and the amylin receptor agonist

Effects on liver Despite the lack of expression of GIPR (41, 191) and GLP-1R (192, 193) in hepatocytes, both GIP and GLP-1 have indirect effects on hepatic lipid and glucose metabolism (194)

PMID 20727946

Thus, increased circulating GLP-1 is invariably reported after bariatric surgery [[211], [212], [213], [214], [215], [216]] and after surgical repositioning of the distal gut (so-called ileal interposition), both of which rapidly expose the L-cells to incoming incompletely digested nutrients [144]